You are here

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
443 Pembrolizumab for BCG refractory non-muscle invasive bladder cancer yields poor recurrence-free survival and high toxicity in patients

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023190025
Dec 202339013
Jan 20245806
Feb 20243201
Mar 20244403
Apr 20243205
May 20243001
Jun 20243404
Jul 20242203
Aug 20242202
Sep 20242401
Oct 20243002
Nov 20245604
Dec 20241803
Jan 20253006
Feb 20251400
Mar 2025002
Apr 2025002
May 2025002
Jun 2025004
Total675089